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EDITORIAL
Artificial Intelligence: Evaluating All Imaging 
for Cardiovascular Disease
David A. Bluemke , MD, PhD; Nadine Kawel- Boehm , MD
At present, at one of the author’s institutions, artificial intelligence (AI) algorithms have already evaluated every chest, spine, and brain computed tomogra-
phy (CT) well before they are evaluated by the radiologist. 
In our environment, the AI algorithms are lurking in the 
background, purposed to detect four clinically meaning-
ful abnormalities: pulmonary embolus (PE), lung nodule, 
cervical spine fracture, and brain hemorrhage. Each of 
these diagnoses has well- defined clinical implications 
and treatments. The rapid triage of CT scans by the AI 
is expected to improve patient outcomes— the radiolo-
gist is alerted and reporting of urgent abnormalities for 
these patients can take precedence over the myriad of 
other patient abnormalities that can wait.
For this "triage" function of AI, there are two main 
disadvantages. First, currently the AI is not always 
right. False positives are relatively common, often due 
to artifacts on less than perfect imaging examinations. 
Second, the AI is not well informed— eg, pulmonary 
emboli may be diagnosed previously; subsequent CT 
scans showing the same PE repeatedly over several 
days or weeks have no urgency. Yet the uninformed AI 
continues to alert the radiologist.
Despite these limitations, all radiologists under-
stand the inevitable trend toward automated diagno-
sis by these AI assistants. Before long, the AI should 
be enabled to read the electronic health record and 
understand if a pulmonary embolus was previously 
reported. If already known, the PE becomes less ur-
gent. The AI can enhance communication faster than 
medical staff: if a stroke is present, it is time to get the 
stroke team mobilized. Despite wonderful progress, a 
chest or brain CT has more abnormalities than PE or 
stroke. Each advanced imaging examination can have 
30 or 40 diagnoses encompassing 50 to 1000 tran-
saxial slices.
As work continues to focus on urgent diagnoses, 
there is another category of abnormality that has clini-
cal meaning yet remains non- standard. We will refer to 
these as "opportunistic" imaging findings— radiology 
findings that primarily affect long- term patient health. 
One example: on an abdominal CT obtained for acute 
cholecystitis, the entire lumbar spine is also imaged. It 
would be a simple matter to have an AI to report lum-
bar spine bone density on every abdominal CT scan. 
The US Preventive Services Task Force (USPSTF) 
recommends dual- energy x- ray absorptiometry (DXA) 
for bone density screening.1 But CT is much more 
accurate for bone density— abdominal CT is not a 
screening test for bone density simply because radia-
tion dose is too high. But bone density— or liver fat or 
atherosclerotic extent— could be quantified for all CT 
scans once obtained for some other purpose, regard-
less of the original indication for CT. Hence the term 
"opportunistic"— the repurposing of imaging tests for 
reasons other than the clinical indication.
All physicians are already somewhat familiar with 
opportunistic imaging concepts— you may order the 
The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.  
Correspondence to: David A. Bluemke, MD, PhD, University of Wisconsin School of Medicine, 600 Highland Ave., Madison, WI 53703. E- mail: dbluemke@
wisc.edu
For Disclosures, see page 3.
© 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative 
Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use 
is non- commercial and no modifications or adaptations are made. 
JAHA is available at: www.ahajournals.org/journal/jaha
Key Words: Editorials ■ arterial ■ artificial intelligence ■ atherosclerosis




 http://ahajournals.org by on June 1, 2021
J Am Heart Assoc. 2021;10:e021540. DOI: 10.1161/JAHA.121.021540 2
Bluemke and Kawel- Boehm AI Evaluation of Imaging
CT scan to check for the size of the aortic aneurysm. 
But along with that comes a host of radiologist state-
ments about nearly every organ system. The current 
problem— those statements are qualitative and are 
often directed toward esoteric abnormalities. Perhaps 
there is a vascular variant, an accessory spleen that 
could simulate a lymph node. These are interesting but 
are not part of the "opportunistic" screening pathway. 
The most common targets of opportunistic imaging 
to date include (1) bone density, (2) coronary artery 
calcium/atherosclerotic disease, and (3) liver steato-
sis (a precursor to the more serious non- alcoholic 
steatohepatitis).
The topic of opportunistic atherosclerotic disease 
evaluation is the subject of an important article by 
Yuan et al in this issue of  the Journal of the American 
Heart Association (JAHA).2 The authors report their 
experience using a deep learning algorithm for ath-
erosclerosis evaluation based on knee magnetic reso-
nance imaging (MRI) obtained for cartilage evaluation, 
as part of the Osteoarthritis Initiative (OAI). The OAI 
(URL: https://www.clini caltr ials.gov. Unique identifier: 
NCT00080171) is a highly respected multi- center co-
hort study designed to evaluate biomarkers for osteo-
arthritis as potential surrogate endpoints for arthritis 
disease onset and progression in ≈4800 study par-
ticipants.3 The rationale for studying arthritis is com-
pelling: the number of Americans with symptomatic 
osteoarthritis was 27 million in 2005. At that time, half 
a million knee replacements were performed for os-
teoarthritis. As the US population ages, this need will 
continue— up to 3.5  million knee replacements are 
expected by 2030.1 The OAI investigators aim to find 
reproducible imaging markers that will help assess the 
effectiveness of drugs that prevent or postpone the 
onset of arthritis.
Yuan et al used knee MRI examinations from the 
OAI in an unexpected manner— to design and test an 
AI to study the development of atherosclerosis of the 
popliteal artery. The characterization of peripheral ar-
tery disease (PAD) is a compelling topic equal to that 
of osteoarthritis. An estimated 27 million individuals in 
Europe and North America are affected by PAD, with 
more than 400  000 annual patient admissions at-
tributed to PAD. Yuan et al evaluated more than half 
a million magnetic resonance MRI slices from 4688 
study participants in the OAI. The extraordinary extent 
of data analysis was made possible by a deep learning 
algorithm that identified more than 9100 popliteal arter-
ies (bilateral arteries were evaluable in most subjects). 
After finding the popliteal artery on the knee MRI, the 
algorithm preceded to determine three parameters: 
the popliteal artery lumen diameter, the wall thickness, 
and the total artery diameter.
An automated, AI- driven analysis of biologically 
important arteries on this order of this magnitude 
has never been previously reported. The important 
implications of this work are wide- ranging and multi- 
factorial. We begin with the contribution of Canton et al 
to advantage of knowledge regarding vascular biology 
and atherosclerosis. Ever since the groundbreaking 
work of Glagov et al on compensatory arterial enlarge-
ment in early atherosclerosis,4 the concept of positive 
and negative remodeling has been central to detec-
tion, treatment, and prevention of CAD. Glagov and 
co- authors studied coronary arteries in 136 hearts at 
autopsy, elegantly showing “coronary arteries enlarge 
in relationship to plaque area and that functionally im-
portant lumen stenosis may be delayed until the lesion 
occupies 40% of the internal elastic lamina area.” Dr 
Glagov and co- authors presciently noted that normal 
lumen areas could be present despite the presence of 
a large plaque.
On the other hand— autopsy studies like that of 
Glagov et al have that one, singularly important bias: 
inclusion only of individuals who have died. Pathologic 
specimens contract and artifacts occur during histol-
ogy preparation. What about in vivo proof? To date, 
noninvasive imaging studies have repeatedly verified 
the so- called Glagov hypothesis in the coronary ar-
teries. But is the Glagov hypothesis universal? Do all 
small to moderate size arteries, such as the renal, ca-
rotid, behave the same way as the coronary arteries? 
Noninvasive imaging has said “yes.”
The study by Yuan et al gives us yet an additional 
vote for yes, the best evidence to date for popliteal 
artery remodeling. Remarkably enlarged popliteal ar-
teries were identified by the AI algorithm in response 
to atherosclerosis. Over a 2- fold range of observed 
arterial wall thicknesses, Canton et al found the cor-
responding vessel size was greater by a factor of 4. 
Yet this apparent vascular enlargement had a limit: 
beyond a wall thickness of 0.9 mm, the size of the ar-
terial lumen was smaller, while the overall vessel diam-
eter was essentially constant. Like the observations of 
Glagov et al, the observations were cross- sectional 
rather than longitudinal change. Yet the observations 
of Canton et al remained consistent after adjustment 
for body size, gender, and cardiovascular risk factors. 
Age was the single strongest factor that correlated 
with mean arterial wall thickness, followed by gender. 
Factors associated with maximal (rather than mean) 
thickness in each study participant were not evalu-
ated at this time.
As suggested above, there are broad implications of 
the author’s results far beyond the OAI data set. Knee 
MRI examinations are extremely common; the authors 
report more than 800 000 such evaluations were done 
in 2017. The initial development of AI is the most chal-
lenging. Researchers must train, validate, and test the 
algorithm by hand. However, subsequent AI software 
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acquisition details, are less intensive. The AI by Canton 
et al, called FRAPPE, could be the basis for wider scale 
algorithms for opportunistic PAD screening based on 
knee MRI. Early treatment, prior to clinically evident 
PAD, would be likely to reduce later morbidity.
But the implications of the work of Canton et al 
go further: a busy academic radiology practice in a 
moderate size hospital frequently performs CT angi-
ography of the extremities. These examinations entail 
about 2500 CT transaxial slices. Current reporting is 
crude and mostly subjective— qualitative adjectives of 
PAD disease severity, with words like mild, moderate, 
or severe. Medical imaging examinations simply have 
too much information for words in a clinical radiology 
report. On the other hand, an AI has little concern for 
the number of imaging slices: means, maximums, ar-
terial segments can be accurately and rapidly labeled. 
Accurate measurement leads to accurate assessment 
of therapeutic response— a step that is currently sub-
jective and incomplete in the work- up of most patients 
for PAD.
Atherosclerosis does not stop below the knee, or 
above the coronary arteries. Our radiology departments 
perform 40 or more different types of imaging exam-
inations for arterial segments throughout the body. In 
the majority of hospitals, none of these imaging tests 
are routinely quantified beyond rough approximately 
(eg, quartiles of stenosis). Yet Canton’s work and the 
underlying foundation of Glagov’s work are clear that 
early atherosclerotic disease is associated with normal 
or even slightly enlarged luminal diameters— precisely 
those vessels that are currently classified as "normal" 
on today’s CT, MRI, or ultrasound studies. Clearly many 
of these are far from normal— atherosclerosis in the ar-
terial wall is the short- term harbinger of severe disease 
that will ultimately develop. Still, we concentrate today’s 
efforts on treatment of severe arterial disease using 
stents and dilatations. Medical therapies are already 
available that reverse atherosclerotic changes. Yet di-
agnostic imaging methods for early atherosclerosis are 
mostly unused. The work of Canton et al helps us en-
vision a future where early atherosclerotic disease is 
readily identified by an AI, ready and waiting for that 
next imaging examination. Once PAD is identified, risk 
factors can then be assessed, therapy prescribed, and 
assessments performed to ensure adequate thera-
peutic response.
The authors are to be congratulated for their work 
in the OAI study. We hope that the next 10 years sees 
continued progress in this area, along with advanced 
therapeutic trials that convincingly demonstrate bene-
fits of early atherosclerotic treatment.
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